Arterial obstruction of the upper limb in Buerger's disease: Its incidence and primary lesion

Harada, Masafumi; Shionoya, Shigehiko

doi:10.1002/bjs.1800660213

Cited by 27 publications

(5 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As the disease progresses, typical calf claudication and eventually ischemic pain at rest and ischemic ulcerations on the toes, feet, or fingers may develop. Ischemia of the upper limbs is clinically evident in 40–50% of patients, but may be detected in 63% of patients by Allen's test [29] and in 91% of patients by arteriogram of the hand and forearm [30]. In the Allen's test, the examiner places the thumbs to occlude the radial and ulnar arteries of one hand of the patient.…”

Section: Clinical Featuresmentioning

confidence: 99%

Thromboangiitis Obliterans (Buerger’s Disease)—Current Practices

Vijayakumar

Tiwari

Prabhuswamy

2013

International Journal of Inflammation

View full text Add to dashboard Cite

Thromboangiitis obliterans (TAO) is a nonatherosclerotic, segmental inflammatory disease that most commonly affects the small and medium-sized arteries and veins in the upper and lower extremities. Cigarette smoking has been implicated as the main etiology of the disease. In eastern parts of the world TAO forms 40–60% of peripheral vascular diseases. Clinical features and angiographic finding are the basis of early diagnosis of TAO. Abstinence from smoking is the only definitive treatment to prevent disease progression. Medical management in form of aspirin, pentoxyfylline, cilostazol, and verapamil increase pain-free walking distance in intermittent claudication, but long term usage fails to prevent disease progression in patients who continue to smoke. Surgical treatment in form of revascularization, lumbar sympathectomy, omentopexy, and Ilizarov techniques help reduce pain and promote healing of trophic changes. Newer treatment modalities like spinal cord stimulation, prostacyclin, bosentan, VEGF, and stem cell therapy have shown promising results. Latest treatment options include peripheral mononuclear stem cell, and adipose tissue derived mononuclear stem cells have been shown to be effective in preventing disease progression, decrease major amputation rates, and improving quality of life.

show abstract

Section: Clinical Featuresmentioning

confidence: 99%

Thromboangiitis Obliterans (Buerger’s Disease)—Current Practices

Vijayakumar

Tiwari

Prabhuswamy

2013

International Journal of Inflammation

View full text Add to dashboard Cite

show abstract

“…Ischaemia of the upper limbs is clinically evident in 40-50% of patients, but may be detected in 63% of patients by Allen's test [14] and in 91% of patients by arteriogram of the hand and forearm [35]. In the Allen's test, the examiner places the thumbs to occlude the radial and ulnar arteries of one hand of the patient.…”

Section: Involvement Of the Upper Limbsmentioning

confidence: 99%

“…The angiographic patterns of TAO are not pathognomonic to this disease [3,66,68], but angiography remains an essential step in the diagnosis of TAO. It shows that TAO virtually always occurs in more than one limb, often in all four, even if not clinically involved [18,35]. The most important diagnostic criterion is the smooth and regular, non-atherosclerotic nature of the artery wall both at the site of, and also proximally to arterial occlusions [3,16,67].…”

Section: Angiographymentioning

confidence: 99%

See 1 more Smart Citation

Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist

Puéchal¹,

Fiessinger

2006

Rheumatology

107

View full text Add to dashboard Cite

Thromboangiitis obliterans (Buerger's disease)--a type of vasculitis in young, mostly male subjects--remains strangely linked to smoking, which determines its occurrence, progression and prognosis by currently unknown mechanisms. It affects the small and medium-sized arteries and veins of the limbs. Despite the usual absence of systemic signs and symptoms, initially intermittent arthritis, even if not observed in all cases, confer on this disease the status of a systemic vasculitis. Diagnosis requires the elimination of many other diseases. The severity of the disease lies in the need for amputation in more than a quarter of all patients. Complete cessation of smoking remains the cornerstone of therapy. Local care is the second essential element of treatment. Prostacycline analogues can be used to help the patient through critical ischaemia. Blockade with antagonists of cannabinoid or endothelin receptors and the use of gene- or cell-based therapy to induce therapeutic angiogenesis have opened up new possibilities for treatment.

show abstract

“…11) Earlystage angiography shows distal or tip occlusion, which was mentioned by Japanese doctors 18,19) as well as Dr. Buerger (Fig. 4).…”

Section: Angiographic Findings and Arterial Occlusionmentioning

confidence: 90%

Are There Any Objections against Our Hypothesis That Buerger Disease Is an Infectious Disease?

Iwai¹,

Umeda²,

Inoue

2012

Annals of Vascular Diseases

View full text Add to dashboard Cite

Arterial obstruction of the upper limb in Buerger's disease: Its incidence and primary lesion

Cited by 27 publications

References 17 publications

Thromboangiitis Obliterans (Buerger’s Disease)—Current Practices

Thromboangiitis Obliterans (Buerger’s Disease)—Current Practices

Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist

Are There Any Objections against Our Hypothesis That Buerger Disease Is an Infectious Disease?

Contact Info

Product

Resources

About